Emerging Company Profile

Araris: universal linkers for antibody-drug conjugates

Emerging Company Profile: Swiss newco is developing peptide linkers that could improve ADC’s therapeutic window

Swiss start-up Araris is developing peptide linkers that could improve the therapeutic window and manufacturing of antibody-drug conjugates. 

Araris is developing antibody-drug conjugate linker technology that could widen the therapeutic